ASX:CPH (Australia)  
Creso Pharma Ltd logo

Creso Pharma Ltd

A$ 0.02 (+5.56%) Nov 30
P/E:
At Loss
P/B:
0.86
Market Cap:
A$ 33.05M ($ 22.23M)
Enterprise V:
A$ 30.26M ($ 20.35M)
Volume:
17.31M
Avg Vol (2M):
11.31M
Also Trade In:
Volume:
17.31M
Market Cap A$:
33.05M
Market Cap $:
22.23M
PE Ratio:
At Loss
Avg Vol (2-Month):
11.31M
Enterprise Value A$:
30.26M
Enterprise Value $:
20.35M
PB Ratio:
0.86
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel, and Australia. The company derives prime revenue from the Europe and Middle East regions.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.9
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.6
Distress
Grey
Safe
Beneish M-Score 11.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.21
9-Day RSI 35.69
14-Day RSI 35.59
6-1 Month Momentum % -41.51
12-1 Month Momentum % -67.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.68
Quick Ratio 1.83
Cash Ratio 1
Days Inventory 102.96
Days Sales Outstanding 76.06
Days Payable 90.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -114.5

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 18.68
Operating Margin % -239.85
Net Margin % -241.92
ROE % -66.31
ROA % -61.79
ROIC % -92.38
ROC (Joel Greenblatt) % -143.78
ROCE % -62.5

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 7.504
EPS (TTM) (A$) -0.015
Beta 2.81
Volatility % 66.18
14-Day RSI 35.59
14-Day ATR (A$) 0.002716
20-Day SMA (A$) 0.0238
12-1 Month Momentum % -67.71
52-Week Range (A$) 0.018 - 0.105
Shares Outstanding (Mil) 1,835.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Creso Pharma Ltd Filings

Document Form Filing Date
No Filing Data

Creso Pharma Ltd Analysis

Share your research